donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

HSDT Helius Medical Technologies

0.557
+0.017+3.19%
Trading Session 08/12 14:47 ET
High
0.595
Open
0.585
Turnover
3.45M
Low
0.531
Pre Close
0.540
Volume
6.12M
Market Cap
2.34M
P/E(TTM)
Loss
52wk High
15.680
Shares
4.20M
P/E(Static)
Loss
52wk Low
0.451
Float Cap
1.96M
Bid/Ask %
-81.13%
Historical High
462.000
Shs Float
3.52M
Volume Ratio
0.64
Historical Low
0.451
Dividend TTM
--
Div Yield TTM
95
P/B
0.33
Dividend LFY
--
Div Yield LFY
17049.53%
Turnover Ratio
173.77%
Amplitude
11.94%
Avg Price
0.563
Lot Size
1
Float Cap
1.96M
Bid/Ask %
-81.13%
Historical High
462.000
Shs Float
3.52M
Volume Ratio
0.64
Historical Low
0.451
Dividend TTM
--
P/B
0.33
Dividend LFY
--
Turnover Ratio
173.77%
Amplitude
11.94%
Avg Price
0.563
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
CEO: Andreeff, Dane Carl
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...